Meet our Board
Collectively responsible for the management, direction and performance of the CompanyChair
Dame Elizabeth Corley
Chair
Appointed Chair in April 2022.
Experience: She first joined the Board as a non-executive Director in September 2021. She has over 45 years’ experience including as CEO of Allianz Global Investors and a non-executive Director of Morgan Stanley Inc. and Pearson plc.
External Appointments: Non-executive director of BAE Systems plc, Chair of the Impact Investing Institute and a Trustee of the British Museum.
Committee Membership: Chair of the Nominations Committee.
Dame Elizabeth Corley
Chair
Appointed Chair in April 2022
Experience: She first joined the Board as a non-executive Director in September 2021. She has over 45 years’ experience including as CEO of Allianz Global Investors and a non-executive Director of Morgan Stanley Inc. and Pearson plc.
External Appointments: Non-executive director of BAE Systems plc, Chair of the Impact Investing Institute and a Trustee of the British Museum.
Committee Membership: Chair of the Nominations Committee.
Executive Directors
Peter Harrison
Group Chief Executive
Appointed Group Chief Executive in April 2016, he will retire on 8 November 2024. Subject to regulatory approval, he will be replaced as Group Chief Executive by Richard Oldfield.
External appointments: Chair of Business in the Community and Director of the Investment Association. He is a Director of FCLT Global, a member of the Advisory Board of Antler Global and a Member of the UK Capital Markets Industry Taskforce.
Peter Harrison
Group Chief Executive
Appointed Group Chief Executive in April 2016, he will retire on 8 November 2024. Subject to regulatory approval, he will be replaced as Group Chief Executive by Richard Oldfield.
Experience: He began his career at Schroders and subsequently held roles at Newton Investment Management, J.P. Morgan Asset Management as Head of Global Equities and Multi-Asset and at Deutsche Asset Management as Global Chief Investment Officer. He was Chairman and Chief Executive of RWC Partners before re-joining Schroders as Global Head of Equities in March 2013.External appointments: Chair of Business in the Community and Director of the Investment Association. He is a Director of FCLT Global, a member of the Advisory Board of Antler Global and a Member of the UK Capital Markets Industry Taskforce.
Richard Oldfield
Chief Financial Officer
Appointed a Director and Chief Financial Officer in October 2023. He will become Group Chief Executive on 8 November 2024, subject to regulatory approval.
Richard Oldfield
Chief Financial Officer
Appointed a Director and Chief Financial Officer in October 2023. He will become Group Chief Executive on 8 November 2024, subject to regulatory approval.
Experience: He is a chartered accountant and was Network Vice Chairman and Global Markets Leader at PricewaterhouseCoopers (PwC) until October 2023 where he led all market-facing activities, initiatives, and strategy. Prior to this he was a member of PwC’s UK Executive Board for five years during which he was Head of Clients and Markets and latterly Head of Strategy and Communications. He also led the UK firm's Banking and Capital Markets Assurance practice and was part of the Assurance Leadership team. His experience includes time spent working across Africa, Europe, Asia and North America.External appointments: Trustee and Audit Committee and Chair of The Duke of Edinburgh International Award Foundation.
Non-Executive Directors
Ian King
Senior Independent Director
Appointed Senior Independent Director in April 2018 having been a non-executive Director since January 2017.
Experience: He was Chief Executive of BAE Systems plc from 2008 to 2017 having been originally appointed to the BAE board as Chief Operating Officer, UK and Rest of the World. Prior to this, he was Chief Executive of Alenia Marconi Systems. He also served as a non-executive Director and Senior Independent Director of Rotork plc until June 2014.
External appointments: Senior Adviser to the Board of Gleacher Shacklock LLP, Chairman of Senior plc, Director of High Speed Two (HS2) Limited and lead non-executive Director for the Department for Transport.
Committee membership: Member of the Nominations and Remuneration Committees.
Ian King
Senior Independent Director
Appointed Senior Independent Director in April 2018 having been a non-executive Director since January 2017.
Experience: He was Chief Executive of BAE Systems plc from 2008 to 2017 having been originally appointed to the BAE board as Chief Operating Officer, UK and Rest of the World. Prior to this, he was Chief Executive of Alenia Marconi Systems. He also served as a non-executive Director and Senior Independent Director of Rotork plc until June 2014.
External appointments: Senior Adviser to the Board of Gleacher Shacklock LLP, Chairman of Senior plc, Director of High Speed Two (HS2) Limited and lead non-executive Director for the Department for Transport.
Committee membership: Member of the Nominations and Remuneration Committees.
Claire Fitzalan Howard
Non-executive Director
Appointed in April 2020.
Experience: She began her career at Kleinwort Benson, where she worked from 1982 to 1987. She subsequently joined Gauntlet Insurance Services, an insurance broking company specialising in high net worth clients, where she had an executive role until 1996 and was a non-executive director between 2004 and 2019. She is a descendant of John Henry Schroder, co-founder of the Schroders business in 1804.
External appointments: Non-executive Director of Caledonia Investments plc, Director and Trustee of the Schroder Charity Trust and a Trustee of a number of charitable foundations.
Committee membership: Member of the Nominations Committee.
Claire Fitzalan Howard
Non-executive Director
Appointed in April 2020.
Experience: She began her career at Kleinwort Benson, where she worked from 1982 to 1987. She subsequently joined Gauntlet Insurance Services, an insurance broking company specialising in high net worth clients, where she had an executive role until 1996 and was a non-executive director between 2004 and 2019. She is a descendant of John Henry Schroder, co-founder of the Schroders business in 1804.
External appointments: Non-executive Director of Caledonia Investments plc, Director and Trustee of the Schroder Charity Trust and a Trustee of a number of charitable foundations.
Committee membership: Member of the Nominations Committee.
Rakhi Goss-Custard
Independent non-executive Director
Appointed in January 2017.
Experience: She is an experienced executive in digital retailing, having spent 12 years at Amazon. Prior to joining Amazon, she held roles at TomTom and in management consultancy in the US.
External appointments: Non-executive Director of Kingfisher plc, Trainline plc and Nisbets plc (unlisted).
Committee membership: Member of the Nominations and Audit and Risk Committees.
Rakhi Goss-Custard
Independent non-executive Director
Appointed in January 2017.
Experience: She is an experienced executive in digital retailing, having spent 12 years at Amazon. Prior to joining Amazon, she held roles at TomTom and in management consultancy in the US.
External appointments: Non-executive Director of Kingfisher plc, Trainline plc and Nisbets plc (unlisted).
Committee membership: Member of the Nominations and Audit and Risk Committees.
Iain Mackay
Independent non-executive Director
Appointed in January 2024.
Experience: Iain is a chartered accountant and was Chief Financial Officer at GSK plc until 2023. He was a member of the GSK leadership team and was responsible for Global Finance and several of GSK’s key global functions including Investor Relations, Digital & Tech and Global Procurement. Prior to joining GSK, Iain was Group Finance Director at HSBC Holdings plc, a position he held for eight years. Iain has lived and worked in Asia, the US and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse.
External appointments: Non-executive Director and Chair of the Audit and Risk Committee of National Grid plc, non-executive Director of UK Government Investments and a Member of the Court of the University of Aberdeen and Chair of its Remuneration Committee.
Committee membership: Chair of the Audit and Risk Committee and Member of the Nominations Committee.
Iain Mackay
Independent non-executive Director
Appointed in January 2024.
Experience: Iain is a chartered accountant and was Chief Financial Officer at GSK plc until 2023. He was a member of the GSK leadership team and was responsible for Global Finance and several of GSK’s key global functions including Investor Relations, Digital & Tech and Global Procurement. Prior to joining GSK, Iain was Group Finance Director at HSBC Holdings plc, a position he held for eight years. Iain has lived and worked in Asia, the US and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse.
External appointments: Non-executive Director and Chair of the Audit and Risk Committee of National Grid plc, non-executive Director of UK Government Investments and a Member of the Court of the University of Aberdeen and Chair of its Remuneration Committee.
Committee membership: Chair of the Audit and Risk Committee and Member of the Nominations Committee.
Leonie Schroder
Non-executive Director
Appointed in March 2019.
Experience: She has held a number of roles in the charity sector and is currently a Director of the Schroder Charity Trust and a number of private limited companies. She is a descendant of John Henry Schroder, co-founder of the Schroders business in 1804.
External appointments: Director and Trustee of the Schroder Charity Trust and a number of private limited companies.
Committee membership: Member of the Nominations Committee.
Leonie Schroder
Non-executive Director
Appointed in March 2019.
Experience: She has held a number of roles in the charity sector and is currently a Director of the Schroder Charity Trust and a number of private limited companies. She is a descendant of John Henry Schroder, co-founder of the Schroders business in 1804.
External appointments: Director and Trustee of the Schroder Charity Trust and a number of private limited companies.
Committee membership: Member of the Nominations Committee.
Annette Thomas
Independent non-executive Director
Appointed in September 2023.
Experience: Annette has 25 years’ experience in leading global publishing and data analytics businesses, across academic, educational and consumer media verticals. Most recently, she served as CEO of Guardian Media Group, a position she held until June 2021. Prior to this, Annette was CEO of the Web of Science Group at Clarivate PLC, a data, analytics and software business focused on research and higher education. She has also served as CEO of Macmillan Publishers and led the digital and global transformation of Nature Publishing Group.
External appointments: Non-executive director of Pearson plc, EcoVadis and OpenClassrooms and a Senior Advisor to General Atlantic.
Committee membership: Member of the Nominations and Remuneration Committees.
Annette Thomas
Independent non-executive Director
Appointed in September 2023.
Experience: Annette has 25 years’ experience in leading global publishing and data analytics businesses, across academic, educational and consumer media verticals. Most recently, she served as CEO of Guardian Media Group, a position she held until June 2021. Prior to this, Annette was CEO of the Web of Science Group at Clarivate PLC, a data, analytics and software business focused on research and higher education. She has also served as CEO of Macmillan Publishers and led the digital and global transformation of Nature Publishing Group.
External appointments: Non-executive director of Pearson plc, EcoVadis and OpenClassrooms and a Senior Advisor to General Atlantic.
Committee membership: Member of the Nominations and Remuneration Committees.
Frederic Wakeman
Independent non-executive Director
Appointed in January 2024.
Experience: Fred was Managing Partner and Head of TMT at Advent International, a leading global private equity investor. During his 23-year career, Fred managed Advent’s London and New York offices and served on both their European and North American Investment Advisory Committees. Fred brings insights into the sustainability and conservation sectors. He also brings experience of private equity and private markets more generally which is of great benefit as we continue to build Schroders Capital, our private markets business.
External appointments: Founder of Blue Endeavor Ventures and Co-Founder of Scale-Up Fund.
Committee membership: Member of the Nominations, Remuneration and Audit and Risk Committees.
Frederic Wakeman
Independent non-executive Director
Appointed in January 2024.
Experience: Fred was Managing Partner and Head of TMT at Advent International, a leading global private equity investor. During his 23-year career, Fred managed Advent’s London and New York offices and served on both their European and North American Investment Advisory Committees. Fred brings insights into the sustainability and conservation sectors. He also brings experience of private equity and private markets more generally which is of great benefit as we continue to build Schroders Capital, our private markets business.
External appointments: Founder of Blue Endeavor Ventures and Co-Founder of Scale-Up Fund.
Committee membership: Member of the Nominations, Remuneration and Audit and Risk Committees.
Deborah Waterhouse
Independent non-executive Director
Appointed in March 2019.
Experience: She has been the CEO of ViiV Healthcare, a major international business, since 2017. ViiV Healthcare is a leading global company, majority owned by GlaxoSmithKline (GSK) and focused on advancing science into HIV treatment, prevention and care. She is a member of the GSK Corporate Executive Team.
External appointments: CEO of ViiV Healthcare and a member of the GSK Corporate Executive Team.
Committee membership: Member of the Nominations and Audit and Risk Committees.
Deborah Waterhouse
Independent non-executive Director
Appointed in March 2019.
Experience: She has been the CEO of ViiV Healthcare, a major international business, since 2017. ViiV Healthcare is a leading global company, majority owned by GlaxoSmithKline (GSK) and focused on advancing science into HIV treatment, prevention and care. She is a member of the GSK Corporate Executive Team.
External appointments: CEO of ViiV Healthcare and a member of the GSK Corporate Executive Team.
Committee membership: Member of the Nominations and Audit and Risk Committees.
Matthew Westerman
Independent non-executive Director
Appointed in March 2020.
Experience: He started his career in 1986 at Credit Suisse First Boston. He subsequently worked at Rothschild & Co where he became Managing Director and Joint Chief Executive of ABN AMRO Rothschild. He joined Goldman Sachs in 2000 and became a partner in 2002. During his tenure he led substantial businesses within the Investment Banking Division. He left Goldman Sachs in 2016 to become Co-Head of Global Banking at HSBC.
External appointments: Director of MW&L Capital Partners, Fellow of Balliol College, Oxford, and Trustee of the UK Holocaust Memorial Foundation.
Committee membership: Chair of the Remuneration Committee and Member of the Nominations and Audit and Risk Committees.
Matthew Westerman
Independent non-executive Director
Appointed in March 2020.
Experience: He started his career in 1986 at Credit Suisse First Boston. He subsequently worked at Rothschild & Co where he became Managing Director and Joint Chief Executive of ABN AMRO Rothschild. He joined Goldman Sachs in 2000 and became a partner in 2002. During his tenure he led substantial businesses within the Investment Banking Division. He left Goldman Sachs in 2016 to become Co-Head of Global Banking at HSBC.
External appointments: Director of MW&L Capital Partners, Fellow of Balliol College, Oxford, and Trustee of the UK Holocaust Memorial Foundation.
Committee membership: Chair of the Remuneration Committee and Member of the Nominations and Audit and Risk Committees